Publicaciones (131) Publicaciones de TERESA HERNÁNDEZ-SAMPELAYO MATOS

2024

  1. COVID-19: On the threshold of the fifth year. The situation in Spain

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 37, Núm. 1, pp. 17-28

  2. Respiratory syncytial virus: A new era

    Revista Espanola de Quimioterapia, Vol. 37, Núm. 2, pp. 134-148

2023

  1. Acute Epstein–Barr virus infection: Diagnostic challenge in young children, risk factors for hospitalisation and cytomegalovirus co-detection

    Acta Paediatrica, International Journal of Paediatrics, Vol. 112, Núm. 6, pp. 1287-1295

  2. Advantages and disadvantages of maintaining the mandatory use of masks in health centers and nursing homes in Spain. How and when is it justified to maintain it?

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 5, pp. 466-469

  3. Insights for COVID-19 in 2023

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 36, Núm. 2, pp. 114-124

  4. Sexually transmitted infections in Spain: Current status

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 36, Núm. 5, pp. 444-465

  5. Status of Herpes Zoster and Herpes Zoster Vaccines in 2023: A position paper

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 36, Núm. 3, pp. 223-235

  6. Tuberculosis in Spain: An opinion paper

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 6, pp. 562-583

2022

  1. Actions and attitudes on the immunized patients against SARS-CoV-2

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 1, pp. 7-15

  2. Booster or additional vaccination doses in patients vaccinated against COVID-19

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 35, Núm. 2, pp. 105-114

  3. COVID in Pediatric Age: an opinion paper

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 4, pp. 333-343

  4. Lessons from COVID-19 for future disasters: an opinion paper

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 5, pp. 444-454

  5. Monkeypox in humans: a new outbreak

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 6, pp. 509-518

  6. Persistence and viability of SARS-CoV-2 in primary infection and reinfections

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 1, pp. 1-6

  7. Pharmacological treatment of COVID-19: an opinion paper

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 35, Núm. 2, pp. 115-130

  8. Risk-score based strategy to minimize antibiotic exposure in children with sickle cell disease and fever

    Infection, Vol. 50, Núm. 2, pp. 499-505

  9. Use of computed tomography for the diagnosis of TB during a paediatric outbreak

    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, Vol. 26, Núm. 12, pp. 1183-1185

2021

  1. Interleukin 6 as a marker of severe bacterial infection in children with sickle cell disease and fever: a case–control study

    BMC Infectious Diseases, Vol. 21, Núm. 1

  2. Longitudinal plasma cytokine concentrations and recurrent wheezing after RSV bronchiolitis

    Cytokine, Vol. 140

  3. New variants of SARS-CoV-2

    Revista Espanola de Quimioterapia, Vol. 34, Núm. 5, pp. 419-428